MedPath

CASPOFUNGINA SANDOZ FARMACÉUTICA 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

CASPOFUNGINA SANDOZ FARMACÉUTICA 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Pending
Register Number

81412

Prescription Type

Uso Hospitalario

Authorization Date

Nov 14, 2016

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number81412
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

CASPOFUNGINAActive
Quantity: 50 mg
Name: CASPOFUNGINA

ATC CLASSIFICATION (3)

J02A
J02AX
J02AX04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.